This MedLibrary.org supplementary page on Therapeutic drug monitoring is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Therapeutic drug monitoring is a branch of clinical chemistry that specializes in the measurement of medication levels in blood. Its main focus is on drugs with a narrow therapeutic index, i.e. drugs that can easily be under- or overdosed.
In pharmacology, many medications are used without monitoring of blood levels, as their dosage can generally be varied according to the clinical response that a patient gets to that substance. In a small group of drugs, this is impossible, as insufficient levels will lead to undertreatment or resistance, and excessive levels can lead to toxicity and tissue damage.
Examples of drugs analysed by therapeutic drug monitoring:
- Aminoglycoside antibiotics (gentamicin)
- Antiepileptics (such as carbamazepine, phenytoin and valproic acid)
- Mood stabilisers, especially lithium citrate
- Antipsychotics (such as pimozide and clozapine)
Therapeutic drug monitoring can also detect poisoning with above drugs, should the suspicion arise.
Wikipedia content modification information:
- This page was last modified on 1 July 2008, at 16:09.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Therapeutic drug monitoring".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.
